William H. Lewis J.D., M.B.A.
Net Worth
Last updated:
What is William H. Lewis J.D., M.B.A. net worth?
The estimated net worth of Mr. William H. Lewis J.D., M.B.A. is at least $75,753,854 as of 19 Dec 2024. He owns shares worth $29,806,596 as insider, has earned $30,477,258 from insider trading and has received compensation worth at least $15,470,000 in Insmed Incorporated.
What is the salary of William H. Lewis J.D., M.B.A.?
Mr. William H. Lewis J.D., M.B.A. salary is $1,190,000 per year as Pres, Chief Executive Officer & Chairman in Insmed Incorporated.
How old is William H. Lewis J.D., M.B.A.?
Mr. William H. Lewis J.D., M.B.A. is 56 years old, born in 1969.
What stocks does William H. Lewis J.D., M.B.A. currently own?
As insider, Mr. William H. Lewis J.D., M.B.A. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Insmed Incorporated (INSM) | Pres, Chief Executive Officer & Chairman | 233,924 | $127.42 | $29,806,596 |
What does Insmed Incorporated do?
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
William H. Lewis J.D., M.B.A. insider trading
Insmed Incorporated
Mr. William H. Lewis J.D., M.B.A. has made 36 insider trades between 2012-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 400,000 units of INSM stock on 25 Jun 2019. As of 19 Dec 2024 he still owns at least 233,924 units of INSM stock.
Insmed Incorporated key executives
Insmed Incorporated executives and other stock owners filed with the SEC:
- Dr. Martina Flammer M.B.A., M.D. (61) Chief Medical Officer
- Mr. Roger Adsett (56) Chief Operating Officer
- Mr. William H. Lewis J.D., M.B.A. (56) Pres, Chief Executive Officer & Chairman
- Ms. Christine A. Pellizzari J.D. (57) Consultant
- Ms. Sara M. Bonstein MBA (44) Chief Financial Officer